학술논문
Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.
Document Type
article
Author
Source
Blood cancer journal. 5(2)
Subject
Language